Home/ Supplements/ Lysine/ L-Lysine

L-Lysine

product on market Capsule Havasu Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for L-Lysine
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
60
Servings
Amino acid/Protein
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mg
Market median: 500.0mg (159 products)

Other Ingredients

Gelatin Magnesium Stearate Silicon Dioxide Rice Flour
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: Take 1 capsule, 1-3 times daily preferably after a meal, or as directed by a health care professional.

Warnings & Precautions

Warning: Use only as directed.

Do not use if you are pregnant or nursing, have a serious medical condition, or use prescription medications.

For adult use only.

Keep out of reach of children.

Do not use if safety seal is damaged or missing.

Formulation Notes

Supports immune & respiratory health

Supports collagen synthesis

Supports Calcium absorption

Additional Information

Formulated in the USA Good Manufacturing Practice consistant quality Source from a GMP certified facility

60 days Money back guaranteed

Store in a cool, dry place.

Metadata

Product Details

UPC / SKUB07FLS4PVC
DSLD Entry Date2020-04-23
Product TypeAmino acid/Protein
FormCapsule
DSLD ID217675
Data Updated2026-04-11
Research

Research Evidence

3
Research Sources
74
Avg Quality
3
Meta Analysis
A Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2026 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
B Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Lysine →
Compare

Similar Products

View all Lysine products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.